U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1044

1.

Aminolipid biosynthesis promotes colistin tolerance in Acinetobacter baumannii

(Submitter supplied) Acinetobacter baumannii is an ESKAPE pathogen that rapidly develops resistance to antibiotics and persists for extended periods in the host or on abiotic surfaces. Survival in environmental stress such as phosphate scarcity, represents a clinically significant challenge for nosocomial pathogens. In the face of phosphate starvation, certain bacteria encode adaptive strategies, including the substitution of glycerophospholipids with phosphorus-free lipids. more...
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL34857
6 Samples
Download data: XLS
Series
Accession:
GSE276010
ID:
200276010
2.

The response to desiccation in Acinetobacter baumannii

(Submitter supplied) The long-term resistance to desiccation on abiotic surfaces is a key determinant of the adaptive success of Acinetobacter baumannii as a healthcare-associated bacterial pathogen. Here, the cellular and molecular mechanisms enabling A. baumannii to resist desiccation and persist on abiotic surfaces were investigated. Experiments were set up to mimic the A. baumannii response to air-drying that would occur when bacterial cells contaminate fomites in hospitals. more...
Organism:
Acinetobacter baumannii ACICU; Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL33973 GPL33972
12 Samples
Download data: TXT
Series
Accession:
GSE249021
ID:
200249021
3.

Transcription regulation by CavA cyclase in Acinetobacter baumannii AB5075

(Submitter supplied) We perform RNA-seq for comparison of deleted cavA wiht empty vector and complemented strains in A. baumannii AB5075 in order to assess the transcription regulation uder the control of this cyclase. A. baumannii AB5075 ΔcavA EV and ΔcavA+cavA cultures were grown in LB medium with 1mM IPTG (3 biological replicates per strain) until reaching mid-exponential phase. At this point, cells were harvested, treated with RNAlate for preservation of total RNA and stored at -80 C. more...
Organism:
Acinetobacter baumannii AB5075
Type:
Expression profiling by high throughput sequencing
Platform:
GPL32092
6 Samples
Download data: TSV
Series
Accession:
GSE250425
ID:
200250425
4.

Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in Acinetobacter baumannii and Escherichia coli

(Submitter supplied) Inosine 5’-monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting step in the de novo guanine biosynthesis and is conserved from humans to bacteria, where it is called GuaB. We developed a series of potent inhibitors that selectively target GuaB over its human homolog. Here we show that these GuaB inhibitors are bactericidal, generate phenotypic signatures that are distinct from other antibiotics, and elicit different time-kill kinetics and regulatory responses in two important gram-negative pathogens: Acinetobacter baumannii and Escherichia coli. more...
Organism:
Escherichia coli; Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL22143 GPL21433
24 Samples
Download data: TXT
Series
Accession:
GSE275261
ID:
200275261
5.

Competitive Inhibition and Mutualistic Growth in Polymicrobial Infections: Deciphering Staphylococcus aureus – Acinetobacter baumannii Interaction Dynamics

(Submitter supplied) Staphylococcus aureus (Sa) and Acinetobacter baumannii (Ab) are frequently co-isolated from polymicrobial infections that are severe and recalcitrant to therapy. Here, we apply a combination of wet-lab experiments and in silico modeling to unveil the intricate nature of the Ab/Sa interaction using both, representative laboratory strains and strains co-isolated from clinical samples. This comprehensive methodology allowed uncovering Sa's capability to exert a partial interference on Ab by the expression of phenol-soluble modulins. more...
Organism:
Staphylococcus aureus subsp. aureus USA300; Acinetobacter baumannii A118
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL34012 GPL29525
16 Samples
Download data: TXT, XLSX
Series
Accession:
GSE250252
ID:
200250252
6.

Whole transcriptome analysis of Acinetobacter calcoaceticus Aca13 induced by n-hexadecane or naphthalene

(Submitter supplied) Petroleum hydrocarbons are recalcitrant contaminants, which has caused most serious environmental problems. Acinetobacter calcoaceticus Aca13 was isolated from petroleum polluted soil for petroleum biodegradation. Hexadecane and naphthalene were used to incubate with Acinetobacter calcoaceticus Aca13. After incubation, the whole transcriptome was obtained from treated groups and control groups, and then used for RNA sequence and analysis. more...
Organism:
Acinetobacter calcoaceticus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL33521
9 Samples
Download data: TXT
Series
Accession:
GSE235642
ID:
200235642
7.

Alteration of global transcription by the phytochemical Kaempferol in Acinetobacter baumannii AB5075

(Submitter supplied) We perform RNA-seq comparing a treatment with 0.375 mM Kaempferol to a mock treatment (DMSO) in A. baumannii AB5075 in order to describe the alterations in global transcription produced by this phytochemical. A. baumannii AB5075 cultures were grown in LB medium in the presence of 0.375 mM Kaempferol or a DMSO control (3 biological replicates per condition) until reaching mid-exponential phase. At this point, cells were harvested, treated with RNAlater for preservation of total RNA and stored at -80 C. more...
Organism:
Acinetobacter baumannii AB5075
Type:
Expression profiling by high throughput sequencing
Platform:
GPL32092
6 Samples
Download data: TSV
Series
Accession:
GSE212989
ID:
200212989
8.

Phenotypic and transcriptional analysis of the antimicrobial effect of lactic acid bacteria on carbapenem-resistant Acinetobacter baumannii: Lacticaseibacillus rhamnosus CRL 2244 an alternative strategy to fight it

(Submitter supplied) Carbapenem-resistant Acinetobacter baumannii (CRAB) is a recognized nosocomial pathogen with limited therapeutics options. Lactic acid bacteria (LAB) constitute a promising therapeutic alternative. Here we aimed to study the antibacterial properties of a collection of LAB strains using phenotypic and transcriptomic analysis against A. baumannii clinical strains. One strain, Lacticaseibacillus rhamnosus CRL 2244, exerts a strong inhibitory capacity on A. more...
Organism:
Acinetobacter baumannii; Lacticaseibacillus rhamnosus
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL28641 GPL33555
6 Samples
Download data: TXT
Series
Accession:
GSE236782
ID:
200236782
9.

Transcriptome analysis of A.baumannii 98-37-09 wild type compared to YhaK Tn mutant under antibiotic treatment in human serum.

(Submitter supplied) We report the transcriptomic information of wild type (Lab-WT) A.baumannii 98-37-09 and A1S_3277 transposon mutant during the growth in human serum with 0.15 µg/mL levofloxacin
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28641
4 Samples
Download data: CSV, TXT
Series
Accession:
GSE190119
ID:
200190119
10.

Transcriptomic investigation of the modes of action of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii

(Submitter supplied) Carbapenem-resistant Acinetobacter baumannii (CRAB) is a Priority 1 (Critical) pathogen urgently requiring new antibiotics. Polymyxins are a last-line option against CRAB-associated infections. This transcriptomic study utilized a CRAB strain to investigate mechanisms of bacterial killing with polymyxin B, colistin, colistin B and colistin/sulbactam combination therapy. After 4 h of 2 mg/L polymyxin monotherapy, all polymyxins exhibited common modes of action which primarily involved disruption to amino acid and fatty acid metabolism. more...
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28641
18 Samples
Download data: XLSX
Series
Accession:
GSE218219
ID:
200218219
11.

Characterisation of a hybrid histidine kinase controlling acetate metabolism in Acinetobacter baumannii 

(Submitter supplied) RNA sequencing transcriptomics was performed on a highly multidrug resistant A. baumannii strain belonging to international clone I, AB5075_UW and a transposon insertion inactivated mutant of ABUW_0182 (acmS), which encodes a hybrid histidine kinase.Transcriptomics suggests that AcmS controls expression of the genes involved in short-chain fatty acid metabolism in A. baumannii. Biophysical analyses showed ABUW_0182 binds acetic and propionic acid with affinities in a low micromolar range, suggesting they represent the physiological ligands for this hybrid histidine kinase system.
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL23966
6 Samples
Download data: TXT, XLSX
Series
Accession:
GSE183334
ID:
200183334
12.

Transcriptomic analysis of Acinetobacter baumannii exposed to sub-lethal Sono-Fenton inactivation

(Submitter supplied) The trancriptomic changes in Acinetobacter baumannii after Sono-Fenton inactivation was reported. A total of 148 genes were significantly expressed after the treatment. The genes involved in stress related response were up-regulated while the genes responsible for vital cell functioning were down-regulated.
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL30101
2 Samples
Download data: TXT
Series
Accession:
GSE202631
ID:
200202631
13.

Deep learning-guided discovery of a narrow-spectrum antibiotic against Acinetobacter baumannii

(Submitter supplied) Acinetobacter baumannii is a nosocomial Gram-negative pathogen that often displays multidrug-resistance due to its robust outer membrane and its ability to acquire and retain extracellular DNA. Moreover, it can survive for prolonged durations on surfaces and is resistant to desiccation. Discovering new antibiotics against A. baumannii has proven challenging through conventional screening approaches. more...
Organism:
Acinetobacter baumannii ATCC 17978
Type:
Expression profiling by high throughput sequencing
Platform:
GPL33052
7 Samples
Download data: CSV, TSV
Series
Accession:
GSE214305
ID:
200214305
14.

Identification of a novel LysR family transcriptional regulator controlling acquisition of sulfur sources in Acinetobacter baumannii.

(Submitter supplied) RNA sequencing transcriptomics was performed on a highly multidrug resistant A. baumannii strain belonging to international clone I, AB5075_UW and a transposon insertion inactivated mutant of ABUW_1016 (cbl), which encodes a LysR-type transcriptional regulator.Transcriptomics suggests that Cbl controls expression of the genes involved in acquisition and reduction of various sulfur sources in A. baumannii.
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL23966
6 Samples
Download data: TXT, XLSX
Series
Accession:
GSE183337
ID:
200183337
15.

RNA-seq of evolved strains from Acinetobacter baumannii NCCP 16007

(Submitter supplied) Comparison for gene expression of Acinetobacter baumannii NCCP 16007 by evolved strains
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28641
3 Samples
Download data: XLSX
Series
Accession:
GSE217840
ID:
200217840
16.

Genomic and Transcriptional Characterisation of Carbapenem and Colistin Resistance Mechanisms in Klebsiella pneumoniae

(Submitter supplied) The transcriptional, epigenomic, and genomic profiles of K. pneumoniae isolates were characterised to identify novel colistin and carbapenem resistance mechanisms. The genomic DNA and total RNA of the isolates were isolated and sequenced on PacBio.
Organism:
Enterobacter cloacae; Klebsiella pneumoniae; Acinetobacter baumannii; Enterobacter asburiae; Enterobacter bugandensis; Enterobacter cloacae complex sp. R_G8
Type:
Expression profiling by high throughput sequencing; Other
12 related Platforms
22 Samples
Download data: CSV, DIFF, GFF, PDF
Series
Accession:
GSE217148
ID:
200217148
17.

Alteration of global transcription by the artificial sweetener acesulfame K in Acinetobacter baumannii AB5075

(Submitter supplied) We perform RNA-seq comparing a treatment with 1.33% acesulfame K to a mock treatment in A. baumannii AB5075 in order to describe the alterations in global transcription produced by this artificial sweetener. A. baumannii AB5075 cultures were grown in LB medium in the presence of 1.33% acesulfame K or a water control (3 biological replicates per condition) until reaching mid-exponential phase. At this point, cells were harvested, treated with RNAlate for preservation of total RNA and stored at -80 C. more...
Organism:
Acinetobacter baumannii AB5075
Type:
Expression profiling by high throughput sequencing
Platform:
GPL32092
6 Samples
Download data: TSV
Series
Accession:
GSE199706
ID:
200199706
18.

DksA acts as a transcriptional switch in stress and virulence in Acinetobacter baumannii

(Submitter supplied) Ability to redirect limiting cellular resources accurately is key to bacteria for surviving in harsh environments that they often encounter during their lifetime. DksA, a transcriptional initiating factor, plays critical roles in regulating stress responses and antibiotic tolerance. Acinetobacter baumannii has become a major healthcare threat and responsible for both nosocomial and community acquired deadly infections worldwide. more...
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28641
24 Samples
Download data: TSV
Series
Accession:
GSE169081
ID:
200169081
19.

Acinetobacter baumannii response to cefiderocol challenge in human urine

(Submitter supplied) Cefiderocol (CFDC) is a novel chlorocatechol-substituted siderophore approved to treat complicated urinary tract infections and for hospital-acquired and ventilator-acquired pneumonia. In previous work, human fluids, were shown to increase the minimum inhibitory concentration (MICs) of Acinetobacter baumannii against CFDC and reduce the expression of genes related to iron uptake systems, which could explain the need for higher concentrations of CFDC to exert inhibitory action. more...
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28641
12 Samples
Download data: TXT
Series
Accession:
GSE201259
ID:
200201259
20.

Transcriptional response to carbapenem treatment in Acinetobacter baumannii

(Submitter supplied) We report transcriptome sequencing analysis on A. baumannii strain ATCC 17978 cultures treated with or without meropnem at 0.5, 3 and 9 h, in triplicate.
Organism:
Acinetobacter baumannii
Type:
Expression profiling by high throughput sequencing
Platform:
GPL31042
18 Samples
Download data: TXT
Series
Accession:
GSE190441
ID:
200190441
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=txid909768[Organism]|query=1|qty=78|blobid=MCID_676bd25b0bdf8a6e7332549d|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center